 |
|
|
| |
LONG-TERM EFFICACY AND SAFETY OF THE INTERFERON- AND RIBAVIRIN-FREE REGIMEN OF PARITAPREVIR/RITONAVIR AND OMBITASVIR IN HCV GENOTYPE 1B-INFECTED TREATMENT-EXPERIENCED JAPANESE PATIENTS
|
| |
| |
Reported by Jules Levin
APASL 2015
The 24th Conference of the Asian Pacific Association for the Study of the Liver, Istanbul, Turkey, 12-15 March 2015
Kazuaki Chayama, Kazuo Notsumata, Masayuki Kurosaki, Ken Sato, Lino Rodrigues-Jr, Carolyn Setze, Prajakta Badri, Tami Pilot-Matias, Regis A. Vilchez, Hiromitsu Kumada
|
| |
|
|
|
|
|
